711. Cell Collection and Manufacturing of HSPCs, CAR-T Cells, and Other Cellular Therapy Products: Poster III
0 activities
Individualizing apheresis processing volumes using a predictive algorithm: Analysis of the CAR T-cell collection protocol utilized in ACIT001/EXC002, a phase lb/ll trial of decentralized production of CAR T-cells
1 activities
Individualizing apheresis processing volumes using a predictive algorithm: Analysis of the CAR T-cell collection protocol utilized in ACIT001/EXC002, a phase lb/ll trial of decentralized production of CAR T-cells
Preclinical feasibility analysis for Phase I study using adoptive iNKT cell transfer to prevent GVHD
1 activities
Preclinical feasibility analysis for Phase I study using adoptive iNKT cell transfer to prevent GVHD
More than IL 2 Optimizing feeder free NK cell function through cytokine synergy
1 activities
More than IL 2 Optimizing feeder free NK cell function through cytokine synergy
Eltrombopag plus G CSF for peripheral blood stem cell mobilization Final analysis of a single arm Phase 2 trial
1 activities
Eltrombopag plus G CSF for peripheral blood stem cell mobilization Final analysis of a single arm Phase 2 trial
Real world experience with apheresis for gene therapy in transfusion dependent β thalassemia The largest single center report
1 activities
Real world experience with apheresis for gene therapy in transfusion dependent β thalassemia The largest single center report
Current practices organizational structures technologies and challenges in developing atmps A survey by dare NL nxtgen hightech T2EVOLVE and ctiwp of EBMT a gocart coalition initiative
1 activities
Current practices organizational structures technologies and challenges in developing atmps A survey by dare NL nxtgen hightech T2EVOLVE and ctiwp of EBMT a gocart coalition initiative
Etoposide cytarabine pegfilgrastim vs cyclophosphamide granulocyte colony stimulating factor for stem cell mobilization in patients with multiple myeloma A phase III trial
1 activities
Etoposide cytarabine pegfilgrastim vs cyclophosphamide granulocyte colony stimulating factor for stem cell mobilization in patients with multiple myeloma A phase III trial